Another conjugation using Fe3O4/Au with monoclonal antibody EGFR (scFv) showed that scFv was able to deliver Fe3O4/Au to NSCLC in vivo and increased the localization of these nanoparticles to the target site (Lu et al., 2021). This evidence concerns the gene EGFR and non-small cell lung carcinoma.